Home
Drugs
Cisplatin
Clinical Trials

Clinical Trials Related to Cisplatin

Related studies linked through entity extraction aliases.

A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation

Status: RECRUITING
Phase: PHASE1/PHASE2

Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Applicability of PDOX in Patients With Primary Liver Cancer: A Randomized Controlled Trial

Status: RECRUITING
Phase: PHASE3

Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study

Status: RECRUITING
Phase: PHASE2

Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC Patients

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Magrolimab in Combination With Cytotoxic Chemotherapy in Advanced Urothelial Carcinoma

Status: WITHDRAWN
Phase: PHASE1

Correlation Between Myocardial Injury and Intestinal Flora Changes Associated With Oncology Drug Therapy and the Preventive of Probiotics

Status: UNKNOWN
Phase: PHASE4

Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC

Status: RECRUITING
Phase: PHASE2

A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma

Status: RECRUITING
Phase: NA

Efficacy and Safety Study of First-line Treatment With SG001 Plus Chemotherapy ± Bevacizumab Versus Placebo Plus Chemotherapy ±Bevacizumab for Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1)

Status: NOT_YET_RECRUITING
Phase: PHASE3

A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors

Status: TERMINATED
Phase: PHASE2

Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial

Status: RECRUITING
Phase: PHASE3

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

Status: SUSPENDED
Phase: PHASE2/PHASE3

Pemetrexed-free vs. Pemetrexed-based Immunochemotherapy in Metastatic TTF-1 Negative Lung Adenocarcinoma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE4

Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA After One Cylce Neoadjuvant Chemotherpy

Status: RECRUITING
Phase: PHASE3

Durvalumab Combined With GemCis Neoadjuvant Therapy of Resectable Intrahepatic Cholangiocarcinoma With High Recurrence Risk

Status: RECRUITING
Phase: PHASE2